| Desired Health Chiropractic, Llc | |
|
530 W Main St Suite 10 Anoka MN 55303-2063 | |
| (612) 968-3385 | |
| Not Available |
| Full Name | Desired Health Chiropractic, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 530 W Main St, Anoka, Minnesota |
| Authorized Official Name and Position | Desiree Marceline Van Bogart (CHIROPRACTOR) |
| Authorized Official Contact | 6129683385 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Desired Health Chiropractic, Llc 530 W Main St Suite 10 Anoka MN 55303-2063 Ph: (612) 968-3385 | Desired Health Chiropractic, Llc 530 W Main St Suite 10 Anoka MN 55303-2063 Ph: (612) 968-3385 |
| NPI Number | 1467696120 |
|---|---|
| Provider Enumeration Date | 04/26/2009 |
| Last Update Date | 04/26/2009 |
| Medicare PECOS PAC ID | 5092865055 |
|---|---|
| Medicare Enrollment ID | O20090612000159 |
News Archive
Patients with severe asthma who use an internet-supported strategy and daily monitoring of exhaled nitric oxide were able to control their asthma with lower overall dosing of oral corticosteroids than patients who underwent usual care, according to research from the Netherlands.
Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says.
The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467696120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 3290217-2 (Minnesota) | Primary |
| Provider Name | Desiree M Van Bogart |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1457595886 PECOS PAC ID: 2466502422 Enrollment ID: I20090612000157 |
News Archive
Patients with severe asthma who use an internet-supported strategy and daily monitoring of exhaled nitric oxide were able to control their asthma with lower overall dosing of oral corticosteroids than patients who underwent usual care, according to research from the Netherlands.
Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says.
The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.
› Verified 6 days ago
News Archive
Patients with severe asthma who use an internet-supported strategy and daily monitoring of exhaled nitric oxide were able to control their asthma with lower overall dosing of oral corticosteroids than patients who underwent usual care, according to research from the Netherlands.
Medical oncologists have a vital role to play in cancer care, particularly as treatments become ever more complex, a new position statement from the European Society for Medical Oncology says.
The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.
› Verified 6 days ago
Caring Hearts Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 801 E River Rd Apt 217, Anoka, MN 55303 Phone: 763-744-6244 |